The Pan American Health Organization said the United States has lost its measles elimination status. PAHO Director Dr. Jarbas Barbosa accepted a recommendation from an independent panel of eight scientific experts that measles transmission is now endemic in the U.S. after 12 months of continuous spread. The panel also found endemic transmission reestablished in Bolivia and Mexico.
"The commission concluded that endemic measles transmission has now been reestablished in Bolivia, Mexico, and the United States, and recommended that their measles elimination status be withdrawn — a recommendation which I have accepted," Barbosa said at a news briefing on Tuesday.
PAHO Assistant Director Dr. Rhonda Sealey-Thomas said the commission found that 48 of the 52 U.S. states and territories it tracked had measles outbreaks between January 2025 and January 2026.
More than 5,400 measles cases had been reported nationwide in 2026 as of mid-November, according to the source. States have confirmed 10 measles deaths this year: seven in Pennsylvania, one in New York and two in Wisconsin. The source reports that all deaths where vaccination status was reported involved unvaccinated people.
Dr. Daniel Salas, executive manager of PAHO's Special Program for Comprehensive Immunization, said PAHO expects the U.S. to present a corrective action plan in the coming weeks.
The CDC said it will work with states and local partners to restore the U.S. measles elimination status. CDC Director Dr. Erica Schwartz said the designation "is not what protects Americans. Vaccination does." She said the agency has invested $100 million in state and local health departments.
CDC data show kindergarten MMR vaccination coverage fell to 92.4% in the 2025-2026 school year, below the 95% level public health officials generally recommend to prevent sustained transmission.
Researchers at Johns Hopkins University estimate the 2026 outbreaks have an economic cost of nearly $83 million. That total includes $56 million in public health response, almost $25 million in lost productivity and more than $1.8 million in direct medical expenses.